Trademark: 77956610
Word
MESAFEM
Status
Dead
Status Code
606
Status Date
Monday, November 7, 2011
Serial Number
77956610
Mark Type
4000
Filing Date
Thursday, March 11, 2010
Published for Opposition
Tuesday, August 10, 2010
Abandoned Date
Monday, November 7, 2011

Trademark Owner History
Noven Therapeutics, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the treatment of gynecological disorders and conditions, namely, gynecological disorders conditions affecting nervousness, depression, mood, anxiety, and cognitive function, perspiration, headache, palpitation, sleep, and bone and joint pain; pharmaceutical preparations for use in the treatment of sexual dysfunction; pharmaceutical preparations and substances for the treatment of hormonal related diseases, disorders, and deficiencies; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases and disorders, psychological diseases and disorders, cognitive impairment disorders, sleep disorders, panic disorders and anxiety disorders; pharmaceutical preparations and substances for use in the treatment, alleviation and prevention of hot flashes, night awakenings, night sweats, mood changes, and menopausal and post-menopausal related, diseases, disorders and conditions

Trademark Events
Nov 7, 2011
Abandonment Notice Mailed - No Use Statement Filed
Nov 7, 2011
Abandonment - No Use Statement Filed
Apr 7, 2011
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2011
Extension 1 Granted
Apr 5, 2011
Extension 1 Filed
Apr 5, 2011
Teas Extension Received
Oct 5, 2010
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2010
Official Gazette Publication Confirmation E-Mailed
Aug 10, 2010
Published For Opposition
Jul 3, 2010
Law Office Publication Review Completed
Jul 3, 2010
Assigned To Lie
Jun 21, 2010
Approved For Pub - Principal Register
Jun 14, 2010
Assigned To Examiner
Mar 17, 2010
New Application Office Supplied Data Entered In Tram
Mar 15, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24